Evidence map›Paper›PMID 39118089›Full record

ArticleBMC public health2024

HPV vaccine behaviors and intentions among a diverse sample of women aged 27-45 years: implications for shared clinical decision-making.

Jennifer D Allen, Nadia N Abuelezam, Raviv Rose, Katelin Isakoff, Gregory Zimet, Holly B Fontenot

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jennifer D AllenDepartment of Community Health, Tufts University School of Arts and Sciences, 574 Boston Ave, Medford, MA, 02155, USA. Jennifer.allen@tufts.edu.
Nadia N AbuelezamConnell School of Nursing, Boston College, 140 Commonwealth Ave., Chestnut Hill, MA, 02467, USA.
Raviv RoseDepartment of Community Health, Tufts University School of Arts and Sciences, 574 Boston Ave, Medford, MA, 02155, USA.
Katelin IsakoffDepartment of Community Health, Tufts University School of Arts and Sciences, 574 Boston Ave, Medford, MA, 02155, USA.
Gregory ZimetDepartment of Pediatrics, Division of Adolescent Medicine, School of Medicine, Indiana University, 410 W. 10th Street, HS 1001, Indianapolis, IN, 46202, USA.
Holly B FontenotNancy Atmospera-Walch School of Nursing, University of Hawaii at Manoa, 2528 McCarthy Mall, Honolulu, HI, 96822, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Advisory Committee on Immunization Practices issued a shared clinical decision-making (SCDM) recommendation for HPV vaccination in persons aged 27-45. Since expanded eligibility for the vaccine was issued, little information has been available about HPV vaccine behaviors and intentions among women in this age group.

methodsWe conducted a cross-sectional online survey among women aged 27-45 years recruited through a Qualtrics™ respondent panel (N = 324) to answer the following questions (1) What is the prevalence of HPV vaccination among a diverse sample of adult women aged 27-45 years? (2) What are the characteristics of those who have or have not previously been vaccinated? and (3) What factors are associated with the intention to obtain the HPV vaccine among those who had never been vaccinated? Multivariable logistic regression analyses estimated adjusted odds ratios (AORs) and 95% confidence intervals (95% CIs).

resultsOnly 31.1% had at least one dose of the HPV vaccine. In multivariable analyses, those more likely to have been vaccinated were younger and were more likely to believe that the vaccine was effective. Of those unvaccinated or unsure, 54.8% indicated they were likely to get vaccinated in the future. Factors associated with future vaccine intention (compared to those not intending) included beliefs about vaccine testing, perceived likelihood of HPV infection, greater comfort in asking one's provider for vaccination, and prior negative healthcare experiences.

conclusionsOur findings suggest that many women in this age group are interested in HPV vaccination. While the recommendation is for SCDM rather than routine vaccination for all women in this age group, efforts to promote informed decision-making among mid-adult women may include educating women about the rigorous vaccine testing and approval process, their risk factors for HPV infection, and encouraging them to engage in SCDM with their medical providers. Targeted efforts to reach women who have had negative experiences with healthcare may also be needed.

Indexed as

IntentionPapillomavirus InfectionsPapillomavirus VaccinesAdultClinical Decision-MakingCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMiddle AgedPatient Acceptance of Health CareSurveys and QuestionnairesPapillomavirus VaccinesAdult womenAttitudes and behaviorsHPV vaccineHuman papillomavirus

Identifiers

PMID39118089
PMCPMC11308683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.